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Animal studies have shown that behavioral responses to cocaine-related cues are
altered by serotonergic medications. The effects of pharmacological agents on serotonin
receptors 2a (5-HT2A) and 2c (5-HT2C), have yielded results suggesting that selective 5-HT2A
antagonists and 5-HT2C agonists promote the disruption of cocaine-associated memories. One
measure of cocaine related cues in humans is attentional bias, in which cocaine dependent
individuals show greater response latency for cocaine related words than neutral words. Data
from our laboratory shows that cocaine dependent subjects have altered attentional bias
compared to controls.
The purpose of this thesis was to investigate the role of the serotonin system in
attentional bias and impulsivity in cocaine dependent individuals. We focused on the
serotonin transporter, serotonin receptors 2A and 2C and tryptophan hydroxylase 1 and 2
(TPH1 and TPH2). We predicted that attentional bias and impulsivity would be higher in
cocaine dependent individuals who had lower serotonin function.
In the current study, we found a significant association between TPH2 genotype and
attentional bias for the second block of the cocaine Stroop task. There was also a significant
association between average attentional bias and HTTLPR genotype in the cocaine
dependent individuals. The HT2C receptor genotype and attentional bias in our study sample
also showed a significant difference. We did not find a significant difference between the
serotonin 2A receptor variants or the TPH1 variants and attentional bias in the cocaine
dependent group.
In conclusion, the current study suggests that serotonergic medications should be
utilized as pharmacotherapeutic treatment for cocaine addiction. Our results indicate that
TPH2, the serotonin transporter and 2C receptor should be targeted in such a way as to
modulate both, leading to increased synaptic serotonin function.
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1- INTRODUCTION

The definition and public opinion of substance addiction has changed in the last few
decades. What was once viewed as a problem of will, is now known to be a disease.
Several systems are thought to be dysfunctional in drug addiction, including inhibitory,
learning, memory and hormonal systems. As a society, we have come to understand that
addiction is an important issue facing an alarming number of individuals (Leshner 1997).
Severe negative consequences of drug abuse and addiction also include indirect
consequences such as infectious diseases that spread among drug users, crime and
violence.
Many of the changes that result from drug use persist even after the individual ceases
drug use. These changes might be genetic, molecular or cellular, and in turn lead to
functional and behavioral changes. When drug-using individuals want to abstain from
drugs, the major challenges for quitting are likely due to alterations in brain activity,
receptor sensitization/desensitization and gene regulation.
Despite the efforts of clinicians and researchers to find an effective way to rescue an
individual from drug dependence, treatment has not been established. Although early
pharmacotherapeutic endeavors focused on reversing the illicit drug’s primary effects,
recently researchers are working on elucidating the neurobiological adaptations that take
place after chronic abuse (Koob and Volkow 2010). Information on the behavioral,
genetic and epigenetic changes that result from drug use, is increasingly being utilized in
the development of treatment.
Addiction is a disorder which begins with the acute use of a drug and progresses to
chronic drug-seeking. The term addiction refers to the loss of control over drug use
despite unwanted consequences (O'Brien, Volkow et al. 2006). Drug addiction develops
in several stages; initiation of drug use, intermittent to regular use, and, finally, addiction
and relapse (Kreek, Nielsen et al. 2005). Features of addiction are the development of
dependence to the drug, which creates a physiological need of the drug for the individual
to function properly, the development of tolerance, manifested as a need for larger doses
of the drug to attain the same effect, the development of withdrawal, symptoms that
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occur when the drug is discontinued, and relapse, which occurs when after a period of
abstinence, the drug is used again by the drug dependent individual.
The term drug dependence refers to the physiological adaptation to repeated
administration of a drug, and occurs with many drugs, but is also the term used to
clinically diagnose an individual with a substance use disorder (O'Brien, Volkow et al.
2006). For the purposes of this thesis, the term drug dependent will be used to signify
both clinical diagnosis using the DSM-IV and the manifestation of the characteristics of
addiction. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) depicts drug dependence to contain three categories: preoccupation/
anticipation, binge/ intoxication, and withdrawal/ negative affect (1994).
A maladaptive pattern of substance use leading to clinically significant
impairment or distress as manifested by three (or more) of the following,
occurring at any time in the same 12-month period:
1.

2.

3.
4.
5.

6.
7.

tolerance, as defined by either of the following:
a. a need for markedly increased amounts of the substance to
achieve intoxication or desired effect
b. markedly diminished effect with continued use of the same
amount of the substance
withdrawal, as manifested by either of the following:
a. the characteristic withdrawal syndrome for the substance
b. the same (or a closely related) substance is taken to relieve
or avoid withdrawal symptoms
the substance is often taken in larger amounts or over a longer period
than was intended
there is a persistent desire or unsuccessful efforts to cut down or
control substance use
a great deal of time is spent in activates necessary to obtain the
substance (e.g. visiting multiple doctors or driving long distances),
use the substance (e.g. chain-smoking), or recover from its effects
important social, occupational, or recreational activities are given up
or reduced because of substance use
the substance use is continued despite knowledge of having a
persistent or recurrent physical or psychological problem that is
likely to have been caused or exacerbated by the substance (e.g.,
current cocaine use despite recognition of cocaine-induced
depression, or continued drinking despite recognition that an ulcer
was made worse by alcohol consumption)

Table 1: Criteria for Drug Dependence According to the DSM-IV, people are classified
as dependent when they show three or more of the following symptoms within one year
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Drug dependence can also be thought of in terms of changes in neuroadaptive or
neuroendocrine homeostasis. After a drug is chronically administered, adaptive processes
to counteract the drug’s effects take place in the central nervous system. During
withdrawal, these functional neuroadaptive changes are still in place and may produce
the symptoms experienced during abstinence (such as anxiety, mood dysregulation, and
somatic abnormalities) and lead to relapse (Koob, Sanna et al. 1998). For example, rats
exposed to cocaine for 12 hours experience reductions in release of dopamine and
serotonin in the nucleus accumbens (Weiss, Markou et al. 1992; Weiss, Paulus et al.
1992). These changes can persist for different periods of time, depending on the length of
administration (abuse).
On the other hand, the conditioning theory of drug dependence hypothesizes that in
individuals who are cocaine dependent, stimuli which have been conditioned with drug
use can alone produce the desire for cocaine, which can lead to relapse (Weiss,
Ciccocioppo et al. 2001). The conditioning theory implies that once the individual is
exposed to drug-related stimuli in the environment, relapse often follows due to the
pairing of the rewarding actions of the drug with the previously neutral stimulus. A third
approach in conceptualizing drug dependence is by depicting it in terms of impulsivity
and compulsivity (Koob and Volkow 2010). Impulsivity is defined behaviorally as

a predisposition toward rapid, unplanned reactions to internal and external
stimuli without regard for the negative consequences of these reactions to
themselves or others (Moeller, Dougherty et al. 2001).
Compulsivity is defined as

elements of behavior that result in perseveration in responding in the face of
adverse consequences or perseveration in the face of incorrect responses in
choice situations (Koob and Volkow 2010) .
Koob and Volkow hypothesize that impulsivity is important in the beginning stages
of drug addiction: during this time reinforcement drives drug seeking and taking. Both
impulsivity and compulsivity, on the other hand, are important in the later stages:
negative reinforcement, in this case to avoid an aversive state without the drug on board,
3

drives the same behavior in a compulsive automatic way by this point (Koob and Volkow
2010). Additionally, Kreek & Nielsen have proposed that impulsivity is important in the
earlier stages of drug addiction (Kreek, Nielsen et al. 2005).
In a 2008 US survey, over 700,000 individuals used cocaine for the first time, which
averages to 2,000 initiates per day, with the average age at first use being 19.8 years
(SAMHSA 2008) The National Survey on Drug Use and Health revealed that 5.3 million
Americans aged 12 and older had abused cocaine and 1.1 million had abused crack at
least once in 2008 (SAMHSA 2008). Substance abuse has been identified as the nation’s
number one health problem, resulting in more deaths, illnesses, disabilities, and cost to
society than any other preventable disease (Horgan, Skwara et al. 2001). Drugs of abuse
disrupt physiological systems, contributing to drug addiction and relapse. However, we
are only recently beginning to understand the molecular changes that take place during
the development of addiction and during withdrawal (Kreek, Bart et al. 2005).

1.1 – NEUROSCIENCE OF COCAINE
Since its synthesis from the coca plant in 1884, cocaine has been medically used as an
anesthetic, anorectic, cardiovascular stimulant, etc. Recreationally used cocaine can be
found in three common forms: cocaine hydrochloride salt (powder) or freebase and crack
rocks which can be smoked (Goldstein, DesLauriers et al. 2009). Cocaine exerts its
primary effects by blocking neurotransmitter uptake by the dopamine (DAT), serotonin
(SERT) and norepinephrine (NET) transporters (Uhl, Hall et al. 2002). Cocaine can also
exert effects on ligand- and voltage-gated channels by blocking these as well (Uhl, Hall
et al. 2002). Cocaine non-competitively blocks the uptake of these monoamines by
binding to a site on the transporter that is different from the substrate binding site
(McElvain and Schenk 1992). Acute administration of cocaine leads to an increased
level of serotonin in the medial prefrontal cortex and the hypothalamus (Yang, Bao et al.
1992). In the dorsal raphe, acute cocaine also suppresses the spontaneous activity of
serotonin neurons while decreasing the synthesis of serotonin in the striatum, nucleus
accumbens, and medial prefrontal cortex (Galloway 1990).
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Chronic doses of cocaine can increase the number of serotonin uptake sites in
prefrontal cortex and dorsal raphe regions. This in turn can alter the ability of cocaine to
inhibit the serotonergic activity in dorsal raphe neurons (Cunningham, Paris et al. 1992).
A study by Egan et al studied the resulting changes of chronic cocaine treatment on
levels of serotonin (5-HT) and levels of one of its metabolites, 5-hydroxyindoleacetic
acid (5-HIAA) levels in cortex during periods of withdrawal in rats (Egan, Wing et al.
1994). Repeated cocaine injections produced a long-term decrease in 5-HT levels in
frontal cortex regions. There was a relationship between withdrawal time and 5-HT
levels, with longer withdrawal times producing a greater reduction in 5-HT
neurotransmission, “suggesting a progressive reduction” (Egan, Wing et al. 1994). When
cocaine is injected into the ventral tegmental area (VTA), dopamine, norepinephrine and
serotonin increase in a concentration-dependent fashion (Chen and Reith 1994).
Cocaine affects several anatomical areas in the brain, including the ventral tegmental
area, which is important for producing the reinforcing properties of cocaine. The VTA
receives inputs form the 5-HT system and is innervated by norepinephrine (NE)containing neurons. Repeated drug use leads to processes that reverse the resulting
effects of the drug. When an individual abstains from the drug, the compensatory
processes that have developed are still active and may be responsible for the negative
cognitive experience during withdrawal (Winstanley 2007).

1.2 – ATTENTIONAL BIAS

Drugs of abuse are salient stimuli that lead to a strong association between drug cues
and the positive (euphoric) effects of the drug. Substance dependent individuals react to
these cues when they appear in the environment. For example, when alcohol abusers
come into contact with something that is reminiscent of an alcoholic beverage (for
example, seeing a drink or smelling the ethanol) they react to the cue and experience
physiological arousal and a state termed “craving” (Carter and Tiffany 1999). Craving
has been defined as a psychological state where the individual feels an obsessive urge to
repeat drug administration and recapture drug-induced euphoria (Copersino, Serper et al.
5

2004). The expectancies experienced during craving are thought to influence drugseeking behaviors.
Robinson and Berridge synthesized a model where drug-related stimuli attain
incentive-motivational properties, which in turn changes the way an individual reacts to
those stimuli. In this model, when an individual repeatedly administers a substance of
abuse, a neurophysiological response takes place that in turn leads to sensitization with
each subsequent administration. Cravings for the substance develop after the substance
has acquired strong motivational properties and obtaining the substance becomes a
priority (Robinson and Berridge 1993). These incentive-motivational properties take
place as a result of classical conditioning. When the drug user is administering the drug,
stimuli or cues in the environment, after one or several pairings with drug use, begin to
elicit components of the original response that the drug caused. The stimulus from then
on
grabs attention, becomes attractive and ‘wanted’ and thus guides behavior to
the incentive (Robinson and Berridge 1993), p. 261).
Franken extended this model by suggesting when drug-cues are encountered, they
become the focus of attention. This increases craving and attention-grabbing properties
of the stimulus until the substance is acquired and used (Franken 2003).
Attentional orienting is the
selective biasing of information processing towards specific attributes of
events based on changing motivation, volition, or expectation (Lepsien and
Nobre 2006).
It is hypothesized that a network in the parietal-frontal axis handles information from
early stages of perceptual analysis using top-down processing (Lepsien and Nobre 2006).
There are two types of implicit indirect measures of cognitive function used by
researchers: ones that measure a bias in attention towards stimuli that are related to
alcohol or drugs and ones that measure implicit memory associations (Wiers, Bartholow
et al. 2007). Implicit measures provide an automatic measurement of the construct the
researcher is measuring, which may capture the implicit processes responsible for the
behaviors in the natural environment (Wiers, Bartholow et al. 2007). One task that
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measures the extent to which drug related cues direct attention in drug users, or
attentional bias for a drug stimulus, is the Drug Stroop task (Cox, Fadardi et al. 2006).
The original Stroop task was constructed to study interference in verbal naming and
the associated attentional processes (Stroop 1935). The person performing is shown cards
with words that spell out colors in incongruent ink: for example the word “yellow” in
green ink or the word “brown” in red ink. In addition to the color words there are also
rows of Xs which serve as the control stimuli. Stroop and subsequent investigators found
that it takes subjects longer to name the ink color of the color words than the meaningless
rows of Xs, and this effect is also observed with words that are related to colors such as
“sky” and “grass” (Stroop 1935), also reviewed in (Williams, Mathews et al. 1996).
Williams et al suggest that if the word stimulus semantically activates processing, then
interference in color naming is likely to take place (Williams, Mathews et al. 1996).
Different variations of the Stroop task are widely used to measure attentional bias to
words or pictures associated with concerns relevant to a subject’s clinical condition (Cox,
Fadardi et al. 2006). The term bias is used to signify a tendency for an individual to
allocate more attention to certain stimuli that have become salient (for example drugrelated stimuli). Craving and treatment outcome are also associated with attentional bias
in drug users (Copersino, Serper et al. 2004; Carpenter, Schreiber et al. 2006; Marissen,
Franken et al. 2006). The Stroop task, therefore, measures the interference these drug
stimuli cause on cognitive commands/processes (Vadhan, Carpenter et al. 2007). It
requires participants to focus on the color of the words or the edge color of pictures while
inhibiting responses to any other feature that word or picture (Cox, Fadardi et al. 2006).
This Stroop task has been used to measure the attentional bias of the cocainedependent subjects to stimuli associated with cocaine use. Using two versions of the
Cocaine Stroop task, Hester and colleagues found that reaction time of cocaine-dependent
subjects to name the color of cocaine-related words was significantly slower than that of
neutral words (Hester, Dixon et al. 2006). For one version of the task, which uses pictures
that are related to cocaine use, evocative (snakes, erotica, mutilated body parts, etc), or
neutral, cocaine users found the drug-related pictures as distracting as the evocative
pictures. Vadhan and colleagues reported that a group of treatment-seeking, cocainedependent subjects showed greater interference by cocaine-related words than
7

nontreatment seeking subjects (Vadhan, Carpenter et al. 2007). In a study by Copersino et
al, three groups of subjects performed the cocaine-word Stroop task: cocaine dependent
patients, patients with schizophrenia and cocaine dependent patients with comorbid
schizophrenia (Copersino, Serper et al. 2004). There was a significant difference
between reaction time for cocaine words compared to neutral words only in the cocaine
patient group.
The above studies suggest that cocaine-related stimuli acquired incentive properties in
these subjects. In an addiction treatment study, attentional bias to the cocaine-related
stimuli in the cocaine-dependent subjects was associated with worse treatment outcome
(Carpenter, Schreiber et al. 2006). Attentional bias was also associated with cocaine
craving severity ratings (Copersino, Serper et al. 2004). Taken together, these studies
suggest the experimental utility of investigating attentional bias in cocaine-dependent
subjects using the cocaine Stroop task. The Stroop task is thought to detect an alteration
in attentional processing in which drug-related cues are more salient and therefore
capture attention better.

1.3 – IMPULSIVITY

Recent models of addiction include the idea that drug users have elevated impulsivity
and poor inhibitory control due to compromised executive function, which is any higher
order brain function, usually processed by the frontal lobe (Field and Cox 2008).
Dysfunction in the prefrontal cortex might result in an inability to inhibit impulses to
react to increased incentive salience of conditioned drug cues (Dawe, Gullo et al. 2004).
Impulsivity has also been classified as an endophenotype or vulnerability trait for
stimulant dependence (Ersche, Turton et al. 2010).
Impulsive behavior is comprised of several independent dimensions, but some
commonalties include behavioral disinhibiton, “intolerance of delay to rewards,” quick
decision making without consideration of consequences, hyperactivity and poor
attentional ability (Winstanley 2007). Moeller has suggested that impulsivity incorporates
multiple distinct psychological concepts (Moeller, Barratt et al. 2001).
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The Barratt Impulsiveness Scale version 11 (BIS-11) is a widely-used questionnaire for
measuring impulsivity. However, multiple paradigms to measure impulsive behavior in
both human and non-human subjects are used by investigators. They can be divided into
two categories: those measuring decision making and those measuring impulsive action
(Winstanley 2007).
In addition to the attentional bias for cocaine-related stimuli, cocaine-dependent
subjects also show other cognitive deficits related to dysfunction of prefrontal cortex such
as increased trait impulsivity and impaired inhibitory control. Several studies have
reported that cocaine dependent subjects have significantly higher scores on the BIS-11,
compared to healthy controls (Moeller, Barratt et al. 2004; Moeller, Hasan et al. 2005).
Individuals with substance dependence show a variety of impulse control deficits.
Brain imaging studies have shown that in individuals who have recently stopped using
drugs, the orbitofrontal cortex is less active (Volkow, Wang et al. 2005). This change in
cortical activity may be related to the increased levels of impulsivity seen in drug users
(Volkow, Wang et al. 2005). Abstinent drug using individuals also perform poorly on
gambling tasks, and made premature-like responses on the immediate and delayed
memory task (IMT/DMT) (Moeller, Hasan et al. 2005).
Cocaine-dependent subjects with high impulsivity and poor inhibitory control may
have difficulty inhibiting their response to cocaine-related stimuli. This relates to
treatment. In a study by Moeller et al, self-report impulsivity, measured by the Barratt
Impulsiveness Scale version 11 (BIS-11), was correlated with severity of cocaine use and
severity of cocaine withdrawal symptoms. The motor impulsivity subscale exhibited the
highest effect. Also, subjects with high impulsivity at baseline, were more likely to drop
out of treatment (Moeller, Dougherty et al. 2001).

1.4- SEROTONIN

Serotonin was discovered 60 years ago and is one of the biogenic amine
neurotransmitters. One of the major neurotransmitters of the nervous systems, serotonin
is responsible for several regulatory functions such as mood states, food intake, and
impulsive aggression. In addition to its involvement in the central nervous system,
9

serotonin also plays a role in cardiovascular, pulmonary, gastrointestinal, and
genitourinary systems (Kandel 2000). Serotonergic neurons modulate the activity of
cortical and subcortical neurons in several ways by activating both inhibitory and
excitatory receptor subtypes (Kandel 2000).
Cell bodies of serotonergic neurons are concentrated in and around the raphe nuclei
of the brain stem. The raphe is composed of three nuclei: the dorsal, median, and the
raphe magnus pallidus. Fibers from neurons in the dorsal raphe innervate dopaminergic
neurons of the substantia nigra and the ventral tegmental area, influencing the levels of
dopamine in these regions. Projections from the median raphe go through the stria
terminalis and fornix to reach the amygdala and hippocampus. Projections also travel to
cortex, superiar colliculi and cerebellum. Serotonin-containing neurons are also found in
the hypothalamus, especially at the suprachiasmatic nucleus—an area that regulates
circadian rhythms which include the sleep-wake cycle. Along with the activity of
noradrenergic neurons, the activity of serotonergic neurons fluctuates with sleep and
wakefulness (Nolte 1999). Cells from the caudal raphe nuclei project to the brainstem
and spinal cord (Nolte 1999). The diverse connectivity of serotonergic neurons allows
this neurotransmitter system to exert effects on a wide range of anatomical regions.

1.4 – SEROTONIN AND CUE REACTIVITY

Rodent studies have shown that behavioral responses to cocaine-related cues are
altered by serotonergic medications (Fletcher, Grottick et al. 2002). Cunningham et al
have investigated the effects of pharmacological agents on serotonin receptors 2A (5HT2A) and 2C (5-HT2C), finding that selective 5-HT2A antagonists and 5-HT2C agonists
promote the disruption of cocaine-associated memories (Nic Dhonnchadha, Fox et al.
2009).
One measure of responsivity to cocaine related cues in humans is attentional bias, in
which cocaine dependent individuals show greater response latency for cocaine related
words than neutral words. Data from our laboratory and other literature shows that
cocaine dependent subjects have altered attentional bias compared to controls and this is
in agreement with other findings (Hester, Dixon et al. 2006; Liu, Lane et al. 2011). Since
10

serotonergic medications alter behavioral responses to cocaine related stimuli in rodents,
it is possible that polymorphisms which were found to be associated with alterations in
the serotonergic system could also affect behavioral responses to cocaine related cues in
humans.
Serotonin synthesis involves several steps and is highly regulated. Serotonin and the
essential amino acid tryptophan from which it is derived, are both indoles (aromatic
compounds), with a five member ring that has nitrogen joined to a benzene (Lodish
2008). Two enzymes are needed to synthesize serotonin: tryptophan hydroxylase, an
oxidase similar to tyrosine hydroxylase and aromatic amino acid decarboxylase (AAAD)
(Kandel 2000). Tryptophan hydroxylase (TPH) is the rate-limiting enzyme responsible
for the synthesis of 5-HT. After tryptophan (an essential amino acid) is hydroxylated, 5hydroxytryptophan decarboxylase catalyzes the final step to result in serotonin, or 5hydroxytryptamine (5-HT) (Nolte 1999).
There are 14 known subtypes of serotonin receptors, classified into seven families.
The 5-HT3 receptor is ionotropic, while the rest are metabotropic. The metabotropic
receptors are G-protein-coupled receptors (GPCRs) and have seven transmembrane
domains. The GPCRs are categorized into four groups based on their main second
messenger system: the 5-HT1-family of receptors uses Gαi/Gαo proteins while the 5-HT2
family couples Gαq proteins. The 5-HT4, 5-HT6, and 5-HT7 receptors use Gs proteins and
the 5-HT5 receptors are unknown (Raymond, Mukhin et al. 2001).
The limbic system is dense in 5-HT1A receptors, with the auto-receptors being
localized in the cell bodies and dendrites of the dorsal and median raphe nuclei (Riad,
Garcia et al. 2000; Lanfumey and Hamon 2004). In the hippocampal area, these receptors
are found post-synaptically and are negatively coupled to adenylyl cyclase (AC) via Gαi
and/or Gαo proteins (De Vivo and Maayani 1986; Weiss, Sebben et al. 1986). 5-HT1A
receptors inhibit neuronal firing through activation of G-protein-gated inwardly rectifying
potassium (GIRK) currents and inhibition of Ca2+ channels (Oleskevich 1995; Sodickson
and Bean 1998).
For the purpose of this thesis, I will focus on the 5-HT2A and 5-HT2C receptors. The
5-HT2A receptors are abundant in prefrontal cortex (Miner, Backstrom et al. 2003). It is
the site of action of many illicit and pharmacological substances, for example, LSD and
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atypical anti-psychotics (Aghajanian and Marek 1999). These receptors have been
characterized by immunohistochemical techniques to the apical dendrite shafts, proximal
to the pyramidal cell soma (Jakab and Goldman-Rakic 1998).
The HT2C receptors are densely expressed in regions implicated in anxiety, mood,
drug-induced hallucinogenesis, reward, neuroendocrine regulation and appetite (Roth,
Berry et al. 1998). They couple to the Gq family of G proteins, activating phospholipase
C to hydrolyze phosphoinositide and produce two second messengers, diacylglycerol and
inositol triphosphate (Roth, Berry et al. 1998). Inositol triphosphate mobilizes calcium
from intracellular stores, increasing the intracellular calcium consentration while
diacylglycerol activates protein kinase C. A study that administered the 5-HT2C agonist
m-chlorophenylpiperazine (m-CPP) showed that compared to healthy volunteers, patients
with alcoholism, anxiety disorders or affective disorders had differences in hormonal and
psychological responses after administration of m-CPP (Charney, Woods et al. 1987;
Joseph-Vanderpool, Jacobsen et al. 1993).
The goal of this thesis is to determine whether attentional bias to cocaine related
stimuli in cocaine dependent subjects is associated with functional polymorphisms of the
serotonin transporter promoter polymorphic region (5-HTTLPR) of the serotonin
transporter gene (SLC6A4), which has been shown to affect serotonin transporter
expression (Hu, Lipsky et al. 2006). Additionally, we will examine the association
between attentional bias and two serotonin receptor polymorphisms, one in the 5-HT2A
and the other in the 5-HT2C receptors. The functional 5-HT2A T102C polymorphism
(rs6311) has been reported to modulate transcriptional activity and the 5-HT2C Cys23Ser
polymorphism (rs6318) has been reported to alter receptor function (Polesskaya and
Sokolov 2002; Okada, Northup et al. 2004)

Serotonin transporter SLC6A4 gene:

The serotonin transporter (5-HTT), encoded by the SLC6A4 gene and located at
17q11.2, codes for a central regulator of serotonin turnover, transporting serotonin from
the synaptic cleft into the presynaptic neuron; terminating serotonin’s action. A 20-23
base pair repeat polymorphism in the SLC6A4 promoter (termed 5-HTTLPR) has been
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shown to affect transcriptional activity of this gene. The short or “S” allele with 14
repeats was shown to have lowered transcriptional activity than that the long or “L” allele
with 16 repeats (Heils, Teufel et al. 1996; Lesch, Bengel et al. 1996; Heils, Mossner et al.
1997).This repeat polymorphism was found to be associated with anxiety-related traits
and depression (Lesch, Bengel et al. 1996). Recently, a single nucleotide polymorphism
(SNP) (A/G) rs25531, was identified in the repeat sequence of the L-allele that
subdivided the polymorphism further into the LA and LG alleles (Hu, Lipsky et al. 2006).
The LG and S alleles were found to have similar low expression levels. This allows the
genotypes to be classified as having high (LA/LA), or low (LA/LG, S/LG, LG/LG, S/S)
transcriptional efficacy. The SA allele is very rare and was not present in our study
sample (Wendland, Martin et al. 2006). More than 20 studies have examined the
relationship of SLC6A4 variants and response to antidepressant treatment [reviewed in
(Horstmann and Binder 2009)]. A meta-analysis of 1400 subjects of different ethnicities
from 15 studies reported diminished response to antidepressant therapy in S-allele
carriers (Serretti, Kato et al. 2007). A more recent meta-analysis found evidence that 5HTTLPR S allele moderates the relationship between stress exposure and development of
clinical depression (Karg, Burmeister et al. 2011). Chronic treatment with cocaine in
vitro causes enhanced surface expression of the serotonin transporter in cells, while postmortem studies have revealed an up-regulation of 5-HTT by cocaine (Little, Kirkman et
al. 1993; Kittler, Lau et al. 2010).
Even though the internal SNP was identified some time ago, and shown to affect the
functionality of the 5-HTT, many subsequent studies only genotype for the bi-allelic
version of the 5-HTTLPR. In the present study, we analyzed our data both ways.

Serotonin receptor 2A HTR2A gene:

The 5-HT2A receptor is encoded by the 5-HTR2A gene located at 13q14.2. Several
common SNPs in the 5-HTR2A gene have been identified and studied: rs6311 (1438A/G), and rs6312 (-783A/G) in the 5’ upstream region, rs6313 (102T/C, Ser34Ser)
and rs6314 (1354C/T, His452Tyr) in the coding region, and rs7997012 in the second
intron of 5-HTR2A. The variants rs6311 (-1438A/G) and rs6313 (102T/C) are reported to
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be in linkage disequilibrium and rs6311 (-1438A/G) is located upstream of two
alternative promoters for HTR2A (Peacock, Warren et al. 1993; Spurlock, Heils et al.
1998). Allele specific expression analysis has shown that the T allele of rs6313 (102T/C)
was expressed at a higher level than the C allele in post-mortem schizophrenic brain
tissues (Polesskaya and Sokolov 2002). The same type of analysis found that the 102C
allele was expressed at lower levels that the 102T allele in brain tissue, but not in
lymphocytes (Fukuda, Koga et al. 2006). Other studies have not found any differences in
allele specific expression for the 102T and 102C alleles (Bray, Buckland et al. 2004; De
Luca, Likhodi et al. 2007).
It has been reported that the HTR2A gene is imprinted, and is expressed only from the
maternally derived allele (Kato, Shimizu et al. 1996; Kato, Ikawa et al. 1998). Another
study however reported monoallelic expression of HTR2A in brain tissue in only 4 of 18
subjects (Bunzel, Blumcke et al. 1998). Both the -1438A/G and the 102C/T variants
create CpG dinucleotide sites, which, have been reported to be methylated at high levels
and HTR2A expression was positively correlated with C-methylation of the -1438 CpG
site (Polesskaya, Aston et al. 2006). The -1438A/G variant has been shown to be
associated with response to treatment with citalopram for major depressive disorder in a
Korean population (Choi, Kang et al. 2005).

Serotonin receptor 2C HTR2C gene:

The serotonin receptor 2C is encoded by the HTR2C gene located on the X
chromosome. A polymorphism at position 23 leads to a cysteine to serine change
(Lappalainen, Zhang et al. 1995). The substituted amino acid is on the extracellular Nterminus of the 5-HT2C receptor. Cysteine is involved in a disulfide bridge formed within
G-protein coupled receptors (GPCRs). The cysteine at position 23 is the only cysteine
residue in the HTR2C gene. It is hypothesized that the serine substitution disrupts
disulfite bond formation within these receptors (Okada, Northup et al. 2004). Also, the
N-terminal region of the 5-HT2C receptor has an extra hydrophobic region which may be
disrupted by the substitution and may affect the receptor’s function (Hurley, Bloem et al.
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1999). Because this receptor is located on the X-chromosome, there’s the possibility for
chimeric expression in females due to X-inactivation.
Okada and colleagues investigated whether Cys23Ser affects ligand affinity,
transduction and constitutive activity of the 5-HT2C receptor. The two alleles were
compared after expression in COS-7 (kidney) cells. Their results demonstrated that this
variant is functional. The serine substitution led to a constitutively more active receptor.
While the results suggested that there may not be a difference between the two alleles
when the receptor is uncoupled and inactive and the variant may not cause a change in
affinity for G proteins or G protein activity when serotonin is present in excess, it can
activate Gq to a higher degree in the absence of 5-HT, suggesting that it is constitutively
more active (Okada, Northup et al. 2004). Constitutive activity is related to receptor
desensitization, meaning constitutively active 5-HT2C receptors are thought to be
constitutively desensitized (Westphal, Backstrom et al. 1995).

Tryptophan Hydroxylase 1 and 2 TPH1 and TPH2 genes

Tryptophan hydroxylase is the rate limiting enzyme in serotonin synthesis (Koe and
Weissman 1966; Jequier, Lovenberg et al. 1967). There are two forms of tryptophan
hydroxylase, tryptophan hydroxylase (TPH1) which is a peripheral subtype (McKinney,
Knappskog et al. 2005) and tryptophan hydroxylase 2 (TPH2) which is the neuronal
subtype (Walther and Bader 2003). TPH1 and TPH2 are highly homologous and share
key structural sequences for enzyme activity. Both TPH1 and TPH2 are expressed in the
human central nervous system, including anatomical regions such as the cortex,
hypothalamus, thalamus, hippocampus, amygdala, cerebellum and raphe nuclei (Zill,
Buttner et al. 2007; Saetre, Lundmark et al. 2010). TPH1 was identified and
characterized first, and is found in the enterochromaffin cells of the gut and in the pineal
gland (Zhang et al, 2006). TPH2 is expressed predominately in the cells in the raphe
nuclei and in peripheral enteric neurons in the gut (Cote, Thevenot et al. 2003; Walther,
Peter et al. 2003).
The gene that encodes TPH1 is located on chromosome 11 in region 11p15.3-p14
(Craig, Boularand et al. 1991). Many variants have been identified in the gene, with
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several associations found relating TPH1 and alcoholism, nicotine dependence, antisocial
behavior and heroin addiction (Nielsen, Goldman et al. 1994; New, Gelernter et al. 1998;
New, Gelernter et al. 1998; Nielsen, Barral et al. 2008), reviewed in (Yuferov, Levran et
al. 2010).
Variants in the TPH2 gene were studied and identified by Nielsen and colleagues
(Nielsen, Barral et al. 2008). The researchers resequenced the TPH2 gene and identified
both new and previously identified variants in individuals with addictive diseases and
healthy volunteers. They looked for associations using the TPH2 variants and the
previously well-studied TPH1 rs1799913 variant. There was a significant interaction
between the TPH1 variant and TPH2 rs4290270 variant in heroin addicted Hispanic
individuals. Based on these findings, in the present study we focused on these two
polymorphisms of the two TPH genes.
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2 – HYPOTHESIZED MOD
MODEL

Figure 1: Proposed model for the role of the serotonergic system in attentional bias and impulsivity.
A) The different steps in the serotonin pathway are depicted by synthesis (1), removal of
neurotransmitter from the synapse (2) and continuation of neurotransmission by the receptors in the
post-synaptic
synaptic or receiving neuron (3).

Figure 2: Proposed model after chronic cocaine exposure
exposure. A decrease in production of serotonin is
hypothesized through reduced expression of the TPH1 and TPH2 genes (1), increased 5-HTT
5
activity,
removing released serotonin from the synapse at a higher rate (2),and
and changes in receptor function
such as sensitization or desensitization for the 55-HT2A and 5-HT2C receptors (3).
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There are four major processes that regulate serotonin system activity: 1) synthesis of the
molecule which involves tryptophan hydroxylase 2) removal of the neurotransmitter by
several key players, the serotonin transporter and breakdown by monoamine oxidase and Laromatic amino acid decarboxylase, and 3) perpetuation of neuronal signaling through
various serotonin receptors. The serotonergic system is a primary target of cocaine. After
cocaine binds the serotonin transporter, the homeostasis of the system is perturbed, leading to
changes that bring the neurotransmitter function back to baseline. There is evidence for
crosstalk between different stages of serotonin function and transmission. For example, the
serotonin 1A receptors are involved in feedback regulation of the serotonin system (Popova,
Naumenko et al. 2010). These receptors are expressed both presynaptically and
postsynaptically and are able to change the firing rate of the neuron, and therefore serotonin
release (Barnes and Sharp 1999; Popova, Naumenko et al. 2010). Acute treatment with a 5HT1A agonist was shown to cause desensitization of 5-HT2A receptors (Carrasco, Van de Kar
et al. 2007). In another experiment, when rats were treated with a 5-HT1A receptor agonist, a
reduction in 5HT1A mRNA levels, 5-HT2A mRNA levels in frontal cortex and hippocampus,
and TPH2 mRNA levels in the midbrain (Popova, Naumenko et al. 2010) . Perturbations in
the serotonin system are also able to cause changes in other neurotransmitter systems.
We hypothesize that chronic cocaine exposure leads to reduced function of the serotonin
transporter, 5-HT2A and 5-HT2C receptors and TPH1 and TPH2 in cocaine dependent
individuals. We expect individuals who carry these variants in these genes that lead to an even
further reduction in serotonin levels at the synapse (for example, individuals with the less
receptors or more transporter expressed in their system) will be the ones that show more
attentional bias for cocaine-cues and higher impulsivity (see specific aims below).
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3 - SPECIFIC AIMS

Specific Aim 1: To examine the relationship between genotype of the serotonin
transporter insertion/deletion polymorphism (5-HTTLPR) and attentional bias in cocaine
users and healthy controls. We hypothesize that cocaine users will show more attentional
bias to cocaine related stimuli and that this higher attentional bias will be associated with
the long (higher expressing, L) form of the serotonin transporter, which has been shown
to reduce serotonin levels at the synapse. We expect cocaine users that are homozygous
for the higher activity (L) form of the transporter to display a higher attentional bias in
the cue reactivity task.

Subaim 1a: To examine the relationship between genotype of the serotonin
transporter insertion/deletion polymorphism and impulsivity in cocaine users and
healthy controls.

Specific Aim 2: To examine the relationship between HTR2A and HTR2C
polymorphisms and attentional bias in cocaine dependent subjects. Pharmacological
agents for the 5-HT2A and 5-HT2C receptors have been shown to differentially affect
cocaine-cue related memories, specifically 5-HT2A receptor antagonists and 5-HT2C
receptor agonists reduce responses to cocaine cues in rats (Liu and Cunningham 2006;
Nic Dhonnchadha, Fox et al. 2009). Therefore, we will genotype cocaine-dependent
subjects for HTR2A and HTR2C receptor polymorphisms. We hypothesize that the T
allele of the HTR2A polymorphism (rs6313), which leads to increased receptor
expression, and the Ser allele of the HTR2C polymorphism (rs6318), which leads to less
transcriptional activity, will both be associated with increased attentional bias.

Subaim 2a: To examine the relationship between HTR2A and HTR2C
polymorphisms and impulsivity in cocaine dependent subjects.
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4– METHODS

4.1 SUBJECTS

Fifty cocaine dependent and 20 healthy volunteer human participants were recruited
through local newspaper advertisements in Houston. The cocaine dependent subjects
were recruited using the Treatment Research Clinic of the Center for Neurobehavioral
Research on Addictions within the UT Health Science Center. After an initial phoneinterview screening, interested subjects had a first intake appointment where they signed
an informed consent form, received a medical evaluation, completed various self-report
neuropsychiatric questionnaires and had blood samples collected.
Inclusion criteria for cocaine dependent subjects were: age of at least 18 years, and
meeting current DSM-IV criteria for cocaine dependence. If the subjects had current
DSM-IV Axis I disorder other than substance abuse/dependence, a current diagnosis of
other substance dependence besides cocaine, any serious non-psychiatric medical illness
requiring ongoing medical treatment or which could affect the central nervous system,
concomitant use of prescription medications that could affect the central nervous system,
or active suicidal ideation, they were excluded from the study. Subjects were not
excluded if they met criteria for alcohol or marijuana abuse.
For control subjects inclusion criteria were age of at least 18 years, and not meeting
current or past DSM-IV criteria for any Axis 1 disorder. Exclusion criteria for control
subjects included the same criteria as the cocaine subjects as well as any current or past
substance abuse or dependence, any non-psychiatric or medical illness needing medical
treatment or which might affect the nervous system, and a positive HIV test. Subjects
were also excluded if they were experiencing suicidal ideation or scored greater than 15
on the Hamilton Depression and Anxiety Scale (Hamilton 1960). For female subjects, a
positive pregnancy test or breast feeding were also exclusion criteria.

4.2 – BEHAVIORAL TASK
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Task.. Depicted above is a representational diagram of words in
Figure 3: The Cocaine Stroop Task
different colored ink. There were 4 categories of word
words presented to subjects in the task: neutral
environmental, neutral furniture, neutral salient and cocaine
cocaine-related.

The Cocaine
ocaine Stroop task was designed to measure attentional bias to cocaine-related
cocaine
stimuli (Hester, Dixon et al. 2006; Vadhan, Carpenter et al. 2007)
2007). In this task, the
participant is presented with words printed in color, and asked to name the color of each
stimulus by pressing mouse buttons covered by colored sticker
stickers. The words (bold Arial font
in size 18) appeared in red, blue or green font color against a bblack
ack background. The
stimulus words were cocaine
cocaine-related
related (for example “Crack” “Rocks,” “High,” “Dealer,” etc)
while others were neutral words (for example “Sofa
“Sofa,”
,” “Oven,” “Cabinet,” “Window,” etc).
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Figure 4: Diagram of stimulus presentation in the Cocaine Stroop task.

The participant was instructed to ignore the meaning of the words, and concentrate
only on naming the color in which the word is written as quickly and as accurately as
possible. A short beep sound was made for incorrect responses. Each subject practiced
for
or 60 trials. Subsequently, ffour
our blocks of words were presented in two parts for the task.
task
After the practice trials, one block of stimulus (cocaine) words, and three blocks of the
neutral words were presented and this was repeated in random order. Attentional
Attenti
bias was
scored as the mean cocaine reaction time minus the mean control reaction time. The
stimulus was displayed on the screen until the subject responded or until 1800
milliseconds (ms) passed.. A blank screen was presented for 500 ms and this was the
inter-trial interval.

4.3 – IMPULSIVITY MEASURE
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Subjects completed the Barratt Impulsiveness Scale. (BIS-11), the most widely used
self-report measure for impulsivity (Patton, Stanford et al. 1995). The BIS-11 is a 30 item
questionnaire which has been used in several previous studies on impulsivity and aggression
(Allen et al. 1998b; Cherek et al. 1997). Each item in the questionnaire is rated from 1 to 4,
and 3 subscales were determined by factor analysis: motor, attentional and nonplanning
impulsiveness (Patton, Stanford et al. 1995; Stanford, Anderson et al. 2009). Items in the
questionnaire include statements such as “I plan tasks carefully”, “I get easily bored when
solving thought problems”, “I change residences”, “I am restless at the theatre or lectures”,
etc. Subjects are instructed to answer quickly and honestly and rate each statement by
marking one of the following options: Rarely/ Never, Occassionally, Often and Almost
Always/ Always.

4.4- DNA SAMPLE COLLECTION

Blood samples were collected by a phlebotomist into an 8 ml EDTA tube. The tube
was placed in a centrifuge and centrifuged at ~1500-2000 X g for 10-15 min at room
temperature. Using a transfer pipet, the plasma, buffy coat, and red blood cell layers were
removed and placed in separate cryostorage tubes and banked at -80 degrees. DNA was
isolated from the buffy coat layer of blood samples using the Qiagen PureGene kit
(Valencia, CA). After purification, DNA quality was measured using a NanoDrop
(Wilmington, Delaware). Some samples were run on E-gels to make sure there was no
degradation of the isolated DNA.

4.5 – GENOTYPING THE 5-HTT

We performed fragment analyses for the two insertion/deletions that are commonly
found in the serotonin transporter SLC6A4 gene: 5-HTTLPR and STIn2. The promoter
polymorphism 5-HTTLPR was genotyped for the repeat polymorphism and the internal SNP
rs25531, to determine the trialleic LA, LG and S serotonin transporter promoter alleles. The
high expressing LA allele was designated L' and the low expressing LG and S alleles were
grouped as S'.
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Primers were designed using Vector NTI (Invitrogen, Carlsbad, CA)
CA and
ordered from the Midland Certified Reagent Company (Midland, Texas).
Texas) The primers
used were 5' GCAACCTCCCAGCAACTCCCTGTA 33' and 5'
GAGGTGCAGGGGGATGCTGGAA 33' (Hu, Oroszi et al. 2005). The 5-HTTLPR
was amplified using ppolymerase chain reaction
eaction (PCR). The PCR mix was comprised
of 18.9 µL H20, 2.5 µµL Invitrogen High Fidelity Buffer, 2.5 µll of 10 mM dNTP mix
, 1 µL
L of 50 mM MgSO4, 0.5 µL of 25 µM concentration of both the forward and
reverse primers, 100 ng DNA and 0.1 µL
L of Invitrogen Platinum High Fidelity Taq
Polymerase. The total volume for each sample was 25uL. The sequence was: 1 cycle:
94°C @ 1 min; 30 cycles: 94°C @ 30 sec; 60°C @ 30 sec, 72°C @ 30 sec; and 1
cycle: 72°C @ 5 min.
Too differentiate between the two forms of the L allele
allele, 5 µL of the PCR
product was subsequently digested with HpaII restriction enzyme (New
New England
Biolabs, Ipswich, MA
MA), which cleaves the PCR product at rs25531when there is a G
allele present. All digested PCR product samples were run on precast polyacrylamide
gels (Bio-Rad,
Rad, Hercules, CA) in 1 % Tris/Borate/EDTA (TBE) buffer solution
(Invitrogen) at 150 volts for 1 hour, stained with ethidium bromide and imaged with
UV light using the Gel DockIt imager (UVP, Upland, CA).. Two people confirmed the
genotypes depicted on the gels.

Figure 5:: Genotyping method for 55-HTTLPR. After
fter PCR amplification, each sample was
digested with HpaII enzyme, which cut if there was a G present in the amplified gene product.
If the G allele was present, this led to two small bands on the gel, as depicted above.
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4.6 - Genotyping TPH1 and TPH2
Genotypes were determined by a 5'-exonuclease fluorescence assay (TaqMan) using
pre-designed TaqMan (Applied Biosystems, Foster City, CA) primer-probe sets (Assay ID
C_2645661_10 for TPH1 variant rs1799913 and C_26385365_10 for TPH2 variant
rs4290270) and analyzed on an ABI Prism 7900 (Applied Biosystems, Foster City, CA) as
previously described (Whitcombe, Brownie et al. 1998; Ranade, Chang et al. 2001). PCR
cycling was performed by incubation at 50ºC for 2 min and at 95ºC for 10 min followed by
40 cycles at 95ºC for 15 s and 62ºC for 1 min. Upon completion of PCR cycling, genotype
analysis was performed on the ABI Prism_ 7900 sequence detection system using SDS 2.2
software (Applied Biosystems, Foster City, CA). All genotype analyses were performed
during a time when the clinical status of the subjects was still blinded. TaqMan assays were
performed in duplicate. We did not observe any inconsistencies between duplicate runs.

4.7- Genotyping the HTR2A and the HTR2C receptor variants
Genotypes for HTR2A and HTR2C were also determined by a 5'-exonuclease
fluorescence assay (TaqMan) using pre-designed TaqMan (Applied Biosystems, Foster
City, CA) primer-probe sets two variants in the HTR2A gene: rs6311 (Applied Biosystems,
Assay ID C_3042197_1_) and rs6318 (Assay ID C_2270166_10) on an ABI Prism 7900
(Applied Biosystems, Foster City, CA). PCR cycling was performed by incubation at 50ºC
for 2 min and at 95ºC for 10 min followed by 40 cycles at 95ºC for 15 s and 62ºC for 1 min.
Genotype of the PCR products was analyzed using the ABI Prism 7900 sequence detection
system using SDS 2.2 software (Applied Biosystems, Foster City, CA). All genotype
analyses were performed during a time when the clinical status of the subjects was still
blinded. Again, assays were performed in duplicate and we observed no inconsistent results
between duplicate plates.
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Figure 6: Genotyping method for TaqMan assays. After PCR amplification, each sample was
analyzed using an ABI fluorescence reader. The allelic discrimination plot above shows the

homozygotes for the first allele close to the X-axis (red) and the homozygotes for the
second allele in the Y-axis (blue). The heterozygotes are depicted in the middle and the
black X’s are negative control samples.

4.8 - Statistical analysis
All variants were tested in the control group for Hardy Weinberg equilibrium. A p
value of less than 0.05 was considered significant. The data was analyzed using several
grouping methods. First we focused on only African American subjects, or all individuals
combined. For both these large groups we examined cocaine users and control subjects
together, only the cocaine users or only the control subjects. Within these groups, we either
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did not control for any other variables, controlled for age and gender or controlled for age,
gender and diagnosis.
Allelic and genotypic analyses were performed for the HTR2A, TPH1 and TPH2 genes.
For the 5-HTTLPR, we analyzed genotype and allele frequencies and also grouped genotype
analysis for LL vs. S carriers. In addition to this, we also analyzed the 5-HTTLPR data as
others have done in the past, without accounting for the internal SNP (simply L or S,
ignoring that LG is transcriptionally similar to S) in order to determine if there was a
difference between the methods.
For the HTR2C, the analysis was different because this gene is on the X-chromosome.
We analyzed the HTR2C data assuming men are homozygotes (looked at both genotypic and
allelic information), focusing on the presence of the C allele, or focusing on the presence of
the G allele.
Analysis of variance, Pearson Chi Square tests and Fischer’s Exact tests were
performed for genotype and allele frequency data for all genes with regard to group (cocaine
or control.) We tested for Hardy-Weinberg Equilibrium in the control groups. None of the
groups violated Hardy-Weinberg Equilibrium for any of the genes. The sample was
analyzed as both ethnically heterogeneous and ethnically homogenous groups. African
Americans comprised the largest group within the sample and were therefore analyzed
separately. One way ANOVA tests were performed to determine significance of the
association between genotypes or allele frequencies and attentional bias. We used a two way
ANOVA test to examine if there were interactions between variables.
Power analyses was performed using the G*Program. Calculations were performed
using the post-hoc option in the G*Power Program.
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5– Results
All genes studied did not violate Hardy-Weinberg equilibrium in the control
groups. The largest ethnic group in our sample was African Americans. To avoid bias
due to population stratification, we analyzed the African American cocaine dependent
subjects separately.
In our study sample, there was a significant difference in age and gender ratio
between the cocaine dependent and healthy control groups, with the cocaine
dependent group being significantly older (p < 0.001) and having significantly fewer
women than the control group (p = 0.003) (refer to Table 1 below).

Age *

Gender**

Ethnicity

Control

Cocaine

31 ± 9

46 ± 8

10 F

8F

10 M

42 M

16 African

34 African

American

American

2 Asian

13 Caucasian

1 Caucasian

2 Hispanic

1 Hispanic

1 Other

Table 2: Demographical Information and differences between groups. Age was significantly
different between control and cocaine groups (* t = 7.07, p < 0.001), as well as the male to
female ratio (** Χ2 = 8.65, p = 0.003).

Our study aimed to determine which cocaine dependent individuals exhibited
the highest attentional bias in the cocaine Stroop task. We analyzed the behavioral
data by grouping all cocaine subjects and comparing the average score for the whole
task and comparing it to control subjects. Overall, cocaine dependent individuals had
significantly higher attentional bias scores than control subjects (p = 0.01). When we
28

analyzed the Cocaine
ocaine Stroop task by blocks, both groups of subjects displayed higher
attentional bias scores for the first block of the task (first 120 stimuli) than the second
block. The scores between both blocks were ssignificantly correlated (Pearson
(
correlation = 0.40, p <0.001) however, and the direction (cocaine dependent group
had higher scores) was consistent between blocks. For the first block of the task, the
cocaine dependent subjects scored significantly higher (p = 0.003 all ethnicities; p =
0.01 AA subjects only)
only). The difference in attentional bias between cocaine and
control groups was not significant for the second block (see Figure 7 below).

Figure 7: Stroop Task Results: cocaine dependent subjects had more
re attentional bias than
controls. There was a decrease in attentional bias for both groups in the second block of the
task (green bar) of the Cocaine Stroop Task.

We administered the BIS
BIS-11
11 to subjects to see if higher impulsivity was
associated with serotonergic gene variants. We hypothesized that higher impulsivity
would be observed in the cocaine dependent subject, a finding that has been
consistently reported in the literature. C
Cocaine
ocaine dependent subjects had higher selfself
report impulsivity in the ttotal scores of the BIS-11 compared to non-drug
drug using
controls (p < 0.001). For the entire group of subjects, ccocaine-dependent
dependent subjects also
displayed higher self--report
report impulsivity on the attentional impulsivity (p < 0.001),
motor impulsivity (p = 0.003) and nonplanning impulsivity (p < 0.001) subscale
scores of the BIS-11.
11. In the ethnically homogeneous group of African American
29

subjects only, BIS-11
11 total (p < 0.001) attentional (p = 0.002) and nonplanning (p <
0.001) were significantly higher, but groups were not significantly different in the
motor subscale scores, although this was still a trend (p = 0.06).

Figure 8: BIS-11 Results
Results: Cocaine dependent subjects scored higher on the BIS-11
BIS
than controls in both the BIS total and subscale scores.
We observed different genetic associations for different blocks of the Cocaine
Stroop task. For the average attentional bias score (both blocks of the task combined)
we observed an association with HTR2C,, for scores of the first block of the task we
observed
ed an effect when examining genotype groups for 5-HTTLPR,, and for the
second block an association with TPH2 was found.
We hypothesized that variants associated with lower serotonin function would
be associated with higher attentional bias and impulsivity in cocaine dependent
individuals. In the ethnically homogenous sample of African American cocaine
dependent individuals, there were several significant findings. We analyzed the data
for 5-HT2C receptor by controlling for gender, and counting males twice (they have
they have only one allele and this is similar to homozygous females). There was a
significant difference between individuals with C and G 5-HT2C receptor alleles in
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average attentional bias for the Stroop task, and subjects with the C allele had higher
attentional bias (p = 0.02)(See figure 8).

Attentional Bias Score

120
100
80
60
40
20
0
CC

CG

GG

HT2RC

Figure 9: The 5-HT2C Variant and attentional bias: The C allele for the HTR2C
gene was associated with higher average attentional bias in cocaine dependent
subjects.
To study the relationship between serotonin transporter function and
attentional bias, we analyzed genotype and allele groups for the 5-HTTLPR variant
and Stroop Task performance scores. For the two different allele groups (see figure
below), we divided subjects into two genotype groups: the L' group which included
the LA/LA genotype and the S' group which was comprised of the LA/ LG, LA/ S,
LG/LG, LG/S and S/S genotypes. The latter group is also referred to as the S-carriers,
because these individuals are likely to have low transporter function. There was a
significant difference in attentional bias for the first block of the task between 5HTTLPR L' and S' genotypes, with the S' genotype exhibiting higher attentional bias
(p = 0.04).
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Figure 10: 5-HTTLPR genotype groups and attentional bias: Cocaine dependent
individuals who were S-carriers for the 5-HTTLPR displayed higher attentional bias
scores for the first block for the first block of the Cocaine Stroop Task.

Tryptophan hydroxylase plays an important role in serotonin synthesis, as the rate
limiting enzyme. For this reason, we hypothesized that tryptophan hydroxylase
variants might be associated with higher attentional bias and impulsivity. The variant
for TPH2 that we chose to study is SNP rs4390270, which has shown association
with addiction-related disorders in the literature. A significant difference between
TPH2 genotype groups was observed for the second block of the Cocaine Stroop
Task. We observed a significant difference between both TPH2 genotypes and alleles
in attentional bias scores (p = 0.03 and p = 0.01, respectively) with the TT genotype
displaying the highest attentional bias for cocaine-related words.
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Figure 11: The TPH2 Variant and attentional bias: For the second block of the
Cocaine Stroop Task, cocaine dependent individuals with the TT genotype displayed
the highest attentional bias scores.

We also hypothesized that there would be a relationship between serotonin
transporter variants and self-report impulsivity scores in cocaine dependent
individuals. We analyzed BIS-11 scores for different genotype and allele groups of
the 5-HTTLPR. In African Americans, there was a significant difference between 5HTTLPR genotypes in scores for BIS total and attentional impulsivity (p= 0.03, p=
0.02 respectively). Unlike the results for attentional bias, it was the L' genotype that
showed association with higher attentional impulsivity.
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Figure 12: 5-HTTLPR
HTTLPR genotype groups and impulsivity
impulsivity: Cocaine dependent users
who were classified to be in the L genotype group displayed higher BIS-11
BIS
attentional
impulsivity scores than the individuals in the S genotype group.
We did not theorize on different relationships between 5-HTTLPR
HTTLPR genotype
groups and impulsivity scores for cocaine users versus healthy controls. In our study
sample, however, we did observe such a converse relationship. For the mixed
ethnicity group, there was a significant interaction between 5-HTTLPR
HTTLPR genotype and
BIS attentional impulsivity (p < 0.05) indicative of a gene environment interaction.
No significant effects were observed in either the mixed or African American control
group. The power for the sample was calculated to be 0.58 for a one way ANOVA.
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Figure 13: 5- HTTLPR genotypes and Impulsivity
Impulsivity: An interaction effect was
observed for genotype groups and Attentional Impulsivity subscale scores of the BISBIS
11 in cocaine versus control subjects.
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6 – DISCUSSION
The purpose of this study was to investigate the role of variants in genes of the
serotonin system in attentional bias and impulsivity in cocaine dependent individuals. We
focused on several genes in the serotonin system, including the serotonin transporter,
those coding for the serotonin receptors 2A and 2C and tryptophan hydroxylase 1 and 2.
We predicted that attentional bias and impulsivity would be higher in cocaine dependent
individuals who had lower serotonin function.

Serotonin Receptor 2C

There was a significant difference between 5-HT2C receptor genotypes in
attentional bias in our study sample. In preclinical studies, 5-HT2C agonists reduce
responses to cocaine cues in rats (Nic Dhonnchadha, Fox et al. 2009) . Variants in the
HTR2C gene have been associated with attention deficit hyperactivity disorder,
schizophrenia, bipolar disorder, obesity in psychiatric patients, and other psychiatric
disorders (Berg, Clarke et al. 2008; Drago and Serretti 2009). These data suggest that the
2C receptor may be involved in not only psychiatric disorders, but also impulse control.
In the present study we genotyped subjects for the rs6318 Cys23Ser variant of the
HTR2C gene, which has been shown to be associated with eating disorders and unipolar
and bipolar affective disorders, reviewed in (Drago and Serretti 2009). Interestingly, this
variant has also been associated with co-morbid bipolar disorder and alcoholism
(Yasseen, Kennedy et al. 2010) Also, a study looking at monoamine metabolite
concentrations in a male population that included alcoholic violent offenders and
controls, found that the polymorphism contributes to variation of CSF 3-Methoxy-4hydroxyphenylglycol (MHPG), a norephinephrine metabolite, with the Ser variant
leading to higher levels of the metabolite, and the authors suggested that the Ser variant is
less responsive to released serotonin (Lappalainen, Long et al. 1999). When cells are
treated with inverse 5-HT2C agonists, the Ser variant displays different desensitization
responses than the Cys variant (Okada, Northup et al. 2004).
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Our findings were that the Ser variant leads to higher average attentional bias in the
cocaine dependent group, and this is in not in agreement with the preclinical literature
(Filip and Cunningham 2002; Liu and Cunningham 2006). Perhaps, like Lappalainen et al
suggested, the cocaine dependent individuals with the Ser variant are less responsive to
released serotonin, due to different desensitization properties of the receptors. Also, it is
possible that in cocaine dependent individuals, an increase in serotonin may take place
after cocaine exposure and the desensitization properties of the receptor might come into
play. Therefore, when serotonin is increased in the synapse, it doesn’t have the agonist
effects that have been associated with reduction of cue reactivity in animal experiments.

Serotonin Transporter

The current study yielded several significant results when we analyzed the 5HTTLPR data. Due to inconsistency in the literature in genotyping 5-HTTLPR, we
performed analysis by considering the internal SNP that influences the 5-HTTLPR’s
function (triallelic method, (Hu, Lipsky et al. 2006) and not considering it (biallelic
method). For the triallelic analysis, there was a significant difference between 5-HTTLPR
genotypes in average attentional bias in cocaine dependent individuals (mixed ethnicity
group). In the ethnically homogenous African American group of cocaine dependent
individuals, when we analyzed attentional bias scores for the first block of the Stroop task
there was a significant difference between 5-HTTLPR genotypes when individuals were
grouped for the presence of the lower functioning variant (L'L' vs L'S' + S'S'), as has
commonly been done in previous literature (Patkar, Berrettini et al. 2002). For the bialleic
analysis, significant effects were observed, although these were all in the control group.
Additionally, there was a significant difference between 5-HTTLPR genotypes in BIS
total and attentional impulsivity subscale scores.
The serotonin transporter is important in that it controls synaptic levels of serotonin
by pumping serotonin molecules back into the presynaptic neuron after they have been
released, and essentially refreshing the synapse after action potential activity. The
functional variant that we studied has been associated with both behavioral and
psychiatric disorders, although findings have been inconsistent. The transporter is
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expressed in cortical and limbic areas that process emotional components of behavior
(Lesch, Bengel et al. 1996). For this reason, the serotonin transporter is also thought to
act on emotional regulation, impulsivity and anxiety as a function of specific contexts
(Courtet, Jollant et al. 2005). S-carriers, individuals possessing at least one S allele, have
also displayed more anxiety-related traits compared to LL individuals in a large study of
healthy volunteers (Lesch, Bengel et al. 1996). S carriers have also been reported to score
lower for coping ability on an emotional appraisal questionnaire, and the investigators
have classified S carriers as being cognitively vulnerable (Szily, Bowen et al. 2008). A
study examining the role of 5-HTTLPR genotype and the influence of framing in decision
making found a significant association between the SS genotype and greater amygdala
activation while making decisions inside a functional magnetic resonance imaging
(fMRI) scanner (Roiser, de Martino et al. 2009).
Transporter genotype has also been associated with acquisition of fear
conditioning, and S-carriers show better acquisition (Garpenstrand, Annas et al. 2001). In
healthy individuals, carriers of the S allele have been reported to perform better on the
Wisconsin Card Sorting Test, a measure of executive function, compared to LL
individuals (Borg, Henningsson et al. 2009). Although previous studies have yielded
inconsistent findings regarding cognitive performance and the 5-HTTLPR, it may be
possible that cocaine dependent individuals who are S carriers experience greater limbic
activation when they encounter cocaine-related cues and this process contributes to
greater attentional bias on the cocaine Stroop task.
Studies investigating the role of the 5-HTTLPR in drug dependence have been
contradictory and inconsistent. In a study examining serotonin transporter variants in
several populations of different geographic origins, there was no association between 5HTTLPR alleles and alcohol dependence (Gelernter, Kranzler et al. 1997). Kremer et al
2005 found the L allele to be more abundant in smokers (Kremer, Bachner-Melman et al.
2005). Mannelli et al. examined the serotonin transporter gene in African American
cocaine and alcohol-dependent individuals and found that people who carried the S allele
had greater severity of alcohol use at admission and showed less improvement after
treatment at follow-up (Mannelli, Patkar et al. 2005). Enoch et al found that the low
activity form (S allele) was more common in a group of African American patients with
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addiction compared to controls (Enoch, Gorodetsky et al. 2010) Another study reported
that the LL genotype was higher in cocaine-dependent individuals, suggesting the long
form of the transporter to be an addiction vulnerability variant. This difference was not
significant when they limited their group to African Americans only, however (Patkar,
Berrettini et al. 2001). Interestingly, one group investigating alcoholism, found that the L
allele is associated with increased craving for alcohol at the beginning of alcohol
withdrawal (Bleich, Bonsch et al. 2007). These last reports are in agreement with our
findings.
We observed a difference in genotype frequencies of the 5-HTTLPR between
cocaine dependent individuals and control subjects when analyzing the total group, which
was ethnically heterogeneous. When we restricted the group to those of African
American ethnicity, this genotypic difference was not significant, but the allele frequency
was different between the two groups. The L allele was more abundant in the cocaine
dependent individuals.
The purpose of this study was to investigate the relationship between 5-HTTLPR
genotype and behavior in cocaine dependent users. The hypothesis was that there is a
gene-environment interaction: cocaine dependent users with the L allele display the most
attentional bias and impulsivity. We found that in cocaine dependent individuals, the SS
individuals showed the highest attentional bias, while in the healthy control group the SS
individuals showed the lowest attentional bias. Although we expected the attentional bias
scores to be close to zero for the control subjects, this was not the case. Within this group
there were subjects that had scores that resembled those in the cocaine group and subjects
who had negative scores (indicating they were biased towards the neutral words). This
could be due to experimental error or the controls in our sample were not honest about
past cocaine use. These findings need to be replicated, due to the small sample size of our
study and uneven genotype groups.

Tryptophan Hydroxylase 2

In the current study, we found a significant difference in attentional bias for the
second block of the cocaine Stroop task between TPH2 SNP rs4290270 genotypes.
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Individuals with the TT genotype displayed the highest attentional bias scores. The TPH2
gene has been reported to be critical in controlling serotonin levels in the brain (Dahl,
Cubells et al. 2006). It has been the focus of many studies of psychiatric and addictive
disorders. Zill et al reported an association between TPH2 variants and major depression
(Zill, Baghai et al. 2004). For the SNP we studied, although not many researchers have
investigated its functional role, one study has identified that it may have functional
effects and another has implicated that the T allele is associated with higher function
(Lim, Pinsonneault et al. 2007; Roche and McKeon 2009).
More studies need to be performed to evaluate rs4290270’s functional role before
we can confidently theorize on the SNP’s influence. However, if the studies mentioned
above are accurate, our data indicate that perhaps higher TPH2 function, which may lead
to higher levels of serotonin being produced, is negatively affecting attentional bias in the
cocaine dependent subjects. A recent publication reported altered levels of serotonin
metabolites in cocaine dependent individuals compared to healthy controls (Patkar,
Rozen et al. 2009). Because the TPH2 variant we genotyped was associated with the
largest effect in attentional bias in our sample of cocaine dependent individuals, we
hypothesize that this gene may be a critical component in the alterations in tryptophan
metabolism and this is in agreement with the data observed by Patkar et al. Even though
the genotype associated with attentional bias in cocaine dependence may be producing
more TPH2 enzyme, which in turn would increase serotonin production, this modulation
in the system may change the synaptic dynamics by leading to modifications in pre and
post-synaptic receptors that may lead to more attentional bias. This variant could be
creating functional differences by splicing, altered binding to enhancers and repressors,
etc.
Studies that have focused on other TPH2 variants that cause functional effects on
the gene product, have found an association with depression (Zhang, Gainetdinov et al.
2005). TPH2 genetic variants have been associated with affective disorders and bipolar
disorder, as well (Harvey, Shink et al. 2004; De Luca, Likhodi et al. 2005). These results
may be relevant to the present study because a high rate of mood disorders in individuals
who use cocaine (abuse or dependent) has been reported (Rounsaville 2004). Reduced
function in the TPH2 enzyme may be a common feature of the pathophysiology of mood
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disorders, impulsivity and cocaine addiction. In genetic vulnerability studies, however,
TPH2 has not always yielded positive findings. Dahl et al studied six variants in the
TPH2 gene that were in linkage disequilibrium with the more commonly studied variants
(specifically rs7963717, rs1386495, rs4760816, rs1007023, rs1386486 and rs1872824)
and did not find an association with the cocaine-dependent phenotype for an ethnically
similar (African American) group of cocaine dependent individuals (Dahl, Cubells et al.
2006).
We did not observe an effect of the TPH2 variants on self-reported impulsivity,
and this is not consistent with other studies that have reported an association between
TPH2 gene variants and impulsivity. Stoltenberg et al. found an association between the
TT genotype in variant rs1366483 and a longer response inhibition time in the Stop Task
in a healthy male population (Stoltenberg, Glass et al. 2006). Another group found an
association between the TT genotype of a TPH2 -703 G/T polymorphism and errors on
an executive control attention task (Reuter, Ott et al. 2007). Perhaps behavioral measures
of impulsivity are more sensitive than self report scores, or the cocaine dependence made
the difference between previously reported results and our sample’s outcome.

Serotonin Receptor 2A

We found a trend between the 5-HT2A receptor TT genotype and increased
attentional bias in the cocaine dependent group. These individuals also had higher selfreported impulsivity scores. Studies show that mRNA for the 2A receptors is most
abundant in the frontal cortex (Pompeiano, Palacios et al. 1994). The 5-HT2A receptor has
been associated with impulsivity: lower receptor density has been observed in impulsive
and violent aggressive individuals (Meyer, Wilson et al. 2008). In preclinical studies, 5HT2A receptor antagonists have been associated with decreasing cue-reinstated behavior
in rats. Blocking the 2A receptors attenuates the locomotor response that’s induced by
cocaine (Fletcher, Grottick et al. 2002). The authors suggested that 2A receptor blockade
modulates locomotor-stimulant properties of cocaine but not the reinforcing effects of the
drug (Fletcher, Grottick et al. 2002). In our results we did not observe a difference in
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motor impulsivity between the genotypes, but perhaps if the sample was larger we would
be able to observe an effect.
An inverse relationship between 5-HT2A receptor density and serotonin levels have
been implicated by the literature. Lower CSF 5-HIAA has been observed in people with
aggressive and impulsive behavior (Brown, Ebert et al. 1982). Increased 5-HT2A receptor
density however has been associated with reduced reactivity to threat related stimuli.
Fisher et al. measured receptor binding using PET and BOLD activation using fMRI in
the amygdalas of healthy volunteers (Fisher, Meltzer et al. 2009). The authors suggested
that serotonin plays a role in integrating affective information between amygdala and
prefrontal cortex, with the 2A receptor being predominant in this modulation (Fisher,
Meltzer et al. 2009). While 5-HT2A receptor mRNA is concentrated in several brain
areas, mRNA for the 2C receptor is more widespread in the CNS, and almost excusively
in the central nervous system (Pompeiano, Palacios et al. 1994). Li and colleagues
studied alterations in 5-HT2A and 5-HT2C receptors in serotonin transporter knockout
mice (Li, Wichems et al. 2003). They found changes in the density of both receptors,
with region- specific alterations. The 2A receptors were increased in hypothalamus and
septum and decreased in the striatum while the 2C receptors were increased in the
amygdala (Li, Wichems et al. 2003). The T allele is associated with higher expression of
the 2A receptor and perhaps, in our sample, this correlated with reduced serotonin
function (Polesskaya and Sokolov 2002). The functional effects of the T allele could be
due to differential splicing, increased binding of enhancers or similar mechanisms that
would lead to higher gene expression .

Tryptophan Hydroxylase 1

TPH1 has been a vulnerability gene for suicidality, and has been thought to be
involved in suicidal behavior, especially violent suicide attempts (Mann, Malone et al.
1997; New, Gelernter et al. 1998; Nielsen, Virkkunen et al. 1998; Abbar, Courtet et al.
2001; Courtet, Jollant et al. 2005). Many variants have been identified in the gene, with
several associations found relating TPH1 and alcoholism, nicotine dependence, antisocial
behavior and heroin addiction, (Nielsen, Goldman et al. 1994; Nielsen, Barral et al. 2008;
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Nielsen, Ji et al. 2008; Yuferov, Levran et al. 2010). We did not find any significant
association between genotypes of TPH1 when we analyzed attentional bias and selfreport impulsivity scores. Perhaps TPH1 is not related to behavioral aspects of drug
dependence that involve prefrontal cortex or top-down processing. TPH1 plays an
important role in central nervous system development but it may not be important to
brain areas involved in executive functioning or sensory processing simply due to
anatomical localization (TPH2 on the other hand would be hypothesized to play a larger
role here).

Summary of genetic results

We observed significant findings for HTR2C, 5-HTTLPR and TPH2 variants. The
HTR2C Cys23Ser SNP was observed to make a difference in average attentional bias
scores of cocaine-dependent individuals. This implies that HTR2C is associated with a
general attentional bias effect in the Cocaine Stroop task.
The 5-HTTLPR, on the other hand, showed an effect on performance in the first
block of the task, which was also when all subjects displayed the highest attentional bias
scores. We hypothesize that this first part of the task relates to attentional impulsivity,
although, this was not observed in the data. The 5-HTTLPR results suggest that synaptic
serotonin levels (modified by the serotonin transporter) might be related to the processes
responsible for the interference that cocaine-related words exert on color naming. Scarriers had the highest attentional bias scores for the first block of the Cocaine Stroop
task, but it was the other genetic group, the L'L' individuals, that had significantly higher
attentional impulsivity scores. These results suggest that the serotonin transporter or
synaptic serotonin levels might play different roles in attentional bias and impulsivity.
There was no correlation between attention bias scores for the first block of the task and
BIS attentional impulsivity, suggesting that the two tasks measure different constructs,
and serotonin transporter function exerts differential effects on attentional bias and
impulsivity.
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We also observed an interaction effect between 5-HTTLPR genotype and BIS
attentional impulsivity in our study sample. This interaction effect might be indicative of
a gene environment interaction. Individuals with the L´L´ genotype who were cocaine
users displayed the highest BIS attentional impulsivity scores. On the other hand, it was
controls with the S´S´ genotype that displayed the highest attentional impulsivity scores.
Cocaine directly interacts with the serotonin transporter, and could have caused this
difference in impulsivity between controls and cocaine-dependent individuals, increasing
attentional impulsivity in individuals who perhaps had lower scores before cocaine use.
Lastly, for the TPH2 variant we studied, individuals with the TT genotype
displayed the highest attentional bias scores for the second block of the task. During the
second block, the attentional bias scores were generally reduced for all subjects. We
hypothesize that this block of the task represents learning or an extinction effect. Subjects
who continue to display high attentional bias in this last block of the task might be
experiencing reduced capacity to learn. On the other hand, the second block of the task
could be representing a completely different and separate process that subjects experience
while performing the task.

Therapeutic implications

In agreement with recent preclinical findings, the current study suggests that
serotonergic medications may be utilized as pharmacotherapeutic treatment for cocaine
addiction. Our results indicate that the serotonin transporter, 2C receptor and tryptophan
hydroxylase 2 should be targeted. There are several FDA approved pharmacological
treatments that target these systems already, for example, selective serotonin reuptake
inhibitors (SSRIs) target the serotonin transporter. Our study results suggest that
increasing serotonin transporter function will reduce attentional bias. Some other possible
therapeutic agents might be partial 5-HT2C receptor agonists, such as metaChlorophenylpiperazine (mCPP). Serotonin receptor agonists however, might lead to
different treatment responses for different genetic backgrounds.
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Limitations

One limitation of this study is the sample size. The control group was too small. In
the total African American group, if the sample sizes were larger, there would likely
more significant findings. The present study was only on average, 0.50 powered to detect
an association between serotonin variant genotypes and attentional bias or self-reported
impulsivity in cocaine dependent individuals. This low power is due to the small number
of subjects in the study. We expect that if we were to increase the sample size (essentially
double it), the study would be .80 powered to have detect a p < 0.05 significant
difference.
In addition, the case and control populations have different age and sex
compositions. It’s possible that the results in the study are confounded by these age and
sex differences. For HTR2C, especially, which is found on the X chromosome, we would
expect sex differences. However, when we covaried for age or sex, we did not find a
difference in the results. Subsequent studies could examine genetic variation of these
genes in larger, better selected populations of cocaine-dependent individuals and control
subjects. Restricting the age range to make sure that age in the study sample is not
responsible (a confounder) for cognitive performance would be beneficial. In future
studies, it would also be beneficial to recruit an equal number of subjects with specific
genotypes for HTR2A and HTR2C as well as TPH1 and TPH2 to participate. This was not
done in the current study.
For behavioral testing, the picture version of the cocaine Stroop Task could be
administered to reduce inter-trial variability for the subjects and reduce the variance in
response. Pictures might provide stimuli that are closer to the environmental triggers that
subjects are exposed to in nature. We observed the biggest attentional bias difference
between the cocaine and control groups in the first block of the Cocaine Stroop task.
Before the subjects performed this block of the task, they completed 60 practice trials. In
the future, we can also record subject responses during the practice trials to see if the
attentional bias is even higher at this earliest stage. Dividing the task in more blocks
might also be beneficial in allowing us to analyze learning processes that might take
place in the progression of the task.
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Early studies using variations of the Stroop task observed an effect for therapy. For
example, patients with depression showed a greater response latency in naming the color
of words associated with depressive symptoms compared to neutral and positive words.
When these patients were tested again after therapy and clinical improvement, they did
not display this difference in performance (Gotlib and Cane 1987). Similar results were
observed in patients with specific phobias and anxiety (reviewed in (Williams, Mathews
et al. 1996). Perhaps in future studies, we can test subjects before and after they undergo
treatment. This way we can investigate the role of serotonin genetics and treatment on
attentional bias scores in cocaine dependent subjects.
In animal models, the serotonin transporter is reported to interact with the products
of other genes, including ones encoding serotonin receptors, other neurotransmitter
systems and neurodevelopmental proteins (Homberg, Nijman et al. 2010) Serotonin
transporter knockout mice provide a low transporter activity model that is similar to
cocaine use. We may choose to focus on other variants that have been reported to be in
linkage disequilibrium with the 5-HTTLPR. For example, it’s been reported that
individuals with a low 5-HTTLPR variant and a gain of function 5-HT3 receptor variant
were 2.5 more likely to be diagnosed with alcohol and drug dependence (Enoch,
Gorodetsky et al. 2010) In future studies, we may study this variant.
Another aspect of genetic variation that needs to be addressed is the possibility that
observed changes are due to epigenetic mechanisms, such as DNA methylation, histone
modifications and miRNA. A complex fine-tuning of neurotransmitters occurs in the
central nervous system and individuals with different genetic backgrounds all undergo
adaptations that establish a homeostatic level of functioning. Epigenetic changes,
however, might reflect more recent changes in gene regulation which might be better
suited to extrapolation due to environmental exposures such as cocaine.
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7 – CONCLUSIONS

Our results suggest that the serotonin system is related in the modification of
attentional bias, and to a lesser extent, impulsivity in this population of cocaine
dependent subjects. The data collected for this thesis did not support our hypothesis
regarding variants that lead to lower serotonin function also lead to higher attentional bias
and impulsivity. For the genetic variants in which we observed significant differences,
our data supported the opposite relationship. Variants that led to higher serotonin
function increased attentional bias.
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